These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 50348)

  • 1. Antigenicity of carcinogen and viral induced sarcomas in inbred and random bred guinea pigs.
    Forni G; Rhim JS; Pickeral S; Shevach EM; Green I
    J Immunol; 1975 Jul; 115(1):204-10. PubMed ID: 50348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM; Millar RC; Ketcham AS
    Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
    Coggin JH
    Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reacting tumor-specific transplantation antigens in methylcholanthrene-induced guinea pig sarcomas.
    Holmes EC; Morton DL; Schidlovsky G; Trahan E
    J Natl Cancer Inst; 1971 Apr; 46(4):693-700. PubMed ID: 4102340
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 9. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efferent enhancement of a methylcholanthrene-induced sarcoma transplantable in strain 13 guinea pigs.
    Berczi I; Tsay HM; Sehon AH
    Eur J Immunol; 1976 Jun; 6(6):453-5. PubMed ID: 991912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
    Chauvenet PH; Smith RT
    Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of guinea pig cells transformed in culture by chemical carcinogens.
    Ohanian SH; McCabe RP; Evans CH
    J Natl Cancer Inst; 1981 Dec; 67(6):1363-8. PubMed ID: 6273639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma.
    Natori T; Law LW; Appella E
    Cancer Res; 1977 Sep; 37(9):3406-13. PubMed ID: 69494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
    LeGrue SJ; Pellis NR; Riley LB; Kahan BD
    Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 17. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correspondence re: Mary S. Leffell and Joseph H. Coggin, Jr. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection. Cancer Res., 37: 4112--4119, 1977.
    Basombrio MA
    Cancer Res; 1978 Oct; 38(10):3568-9. PubMed ID: 80267
    [No Abstract]   [Full Text] [Related]  

  • 19. The major histocompatibility complex of the guinea pig. I. Serologic and genetic studies.
    Geczy AF; de Weck AL; Schwartz BD; Shevach EM
    J Immunol; 1975 Dec; 115(6):1704-10. PubMed ID: 52675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.
    Fritze D; Kern DH; Waldman SR; Pilch YH
    Int J Cancer; 1975 Jan; 15(1):116-31. PubMed ID: 1079201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.